Waldenström Macroglobulinemia
📧 Sign up to get email alerts when something new happens for Waldenström Macroglobulinemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-02-16Clinical Trial Update: Perifosine in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia [Phase 2]
Phase 2 trial evaluating perifosine in patients with relapsed/refractory Waldenström's macroglobulinemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: A Study of Belimumab in Treating Symptomatic Waldenstroms Macroglobulinaemia [Phase 2]
A Phase 2 clinical trial evaluating belimumab for symptomatic Waldenström macroglobulinemia is reported, with no results provided and the tr…
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Trial of AVN-944 in Patients With Advanced Hematologic Malignancies [Phase 1]
A Phase 1 trial evaluating AVN-944 in patients with advanced hematologic malignancies has completed, spanning acute and chronic leukemia, mu…
-
CLINICAL_TRIALS trial_result · 2011-07-15Clinical Trial Update: DT PACE, Tandem Autologous Transplant, Maintenance Therapy for Waldenstrom's Macroglobulinemia Patients [Phase 2]
Phase 2 trial update evaluating DT-PACE with tandem autologous transplant and maintenance therapy for Waldenström macroglobulinemia. The stu…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Bortezomib (Velcade) in Waldenstrom's Macroglobulinemia [Phase 2]
Phase 2 clinical trial of bortezomib (Velcade) in Waldenström's macroglobulinemia and lymphoplasmacytic lymphoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia [NA]
A completed clinical trial update examining the correlation of Fc Gamma RIIIA (CD16) receptor response in patients with Waldenström macroglo…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Sildenafil Citrate in Waldenstrom's Macroglobulinemia [Phase 2]
Phase 2 trial evaluating sildenafil citrate for Waldenström macroglobulinemia has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia [Phase 1, Phase 2]
A Phase 1/2 trial of radiolabeled monoclonal antibody therapy with peripheral stem cell transplantation for lymphoma or Waldenström's macrog…
-
CLINICAL_TRIALS trial_result · 2011-02-21Clinical Trial Update: Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 study evaluating oblimersen sodium in combination with rituximab for recurrent B-cell non-Hodgkin lymphoma completed, with results…
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia [Phase 2]
A completed Phase 2 clinical trial evaluated thalidomide as an anti-angiogenesis therapy in patients with Waldenström macroglobulinemia. The…
-
CLINICAL_TRIALS trial_result · 2009-06-25Clinical Trial Update: Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL) [Phase 2]
This is an interventional Phase 2 trial evaluating a pentostatin, cyclophosphamide, and rituximab regimen for indolent B-cell non-Hodgkin ly…